Back to Authors

Joyce, Joel C.

0009-0002-7300-8516

Mayo Clinic

Medical College of Wisconsin

Citations 2

Pyoderma gangrenosum: a possible cutaneous complication of levamisole‐tainted cocaine abuse
Keith, Phillip J., Joyce, Joel C. , Wilson, Barbara

International Journal of Dermatology | June 5, 2014 | Volume: 54 | Issue: 9 | Pages: 1075-1077

10.1111/ijd.12212 Get It

Superficial Hemosiderotic Lymphovascular Malformation (Hobnail Hemangioma): A Report of Six Cases
Joyce, Joel C. , Keith, Phillip J., Szabo, Sara , Holland, Kristen E.

Pediatric Dermatology | March 6, 2014 | Volume: 31 | Issue: 3 | Pages: 281-285

10.1111/pde.12294 Get It

AbstractHobnail hemangioma (HH), initially termed targetoid hemosiderotic hemangioma, is a rare, often solitary lesion classically characterized by a central brown or violaceous papulonodule surrounded at times by an ecchymotic halo. This lesion is typically found on the trunk or limbs of children or young to middle‐aged adults. Numerous case reports have found HHs to have a reproducible histologic appearance. Although the exact histogenesis of these lesions is unknown, multiple recent immunohistochemical studies suggest a lymphatic origin of these lesions. We present six cases of children with HHs with classic histology but with variability in their clinical appearance. Because the clinical presence of a targetoid halo is inconsistent and the hobnail phenomenon is not specific, we favor the designation of superficial hemosiderotic lymphovascular malformation instead of HH or targetoid hemosiderotic hemangioma as a more unifying term for this rare clinical entity. By eliminating confounding terminologies (in this case, incorporation of “hemangioma” in the name of this entity), we also hope to encourage a swifter change in practice to move away from erroneous diagnostic considerations.